Precision Medicine

Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.

HIT venture capital funding jumps in 2014

Venture capital funding for health IT companies is on the rise in 2014 with $858 million across 163 deals in the first quarter.

Report cites lack of interoperability as biggest barrier to robust IT infrastructure

Lack of interoperability is the biggest obstacle to information exchange, according to a report compiled by an independent group of scientists advising the federal government.

Thumbnail

Room for Improvement

The Institute of Medicine’s 2011 report, Patient Safety and Health IT: Building Safer Systems for Better Care, expressed dismay that patient safety hadn’t improved very much since its landmark 1999 study, To Err is Human.

Healthcare IT integration market predicted to reach $2,745.9M by 2018

The global healthcare IT integration market is forecast to reach $2,745.9 million by 2018, up from $1,737.3 million in 2013, according to a report from global market research and consulting company MarketsandMarkets.

Thumbnail

Engaging Patients in Chronic Disease Management

With so much spent on chronic disease, programs are working to increase patient engagement in an effort to drive down costs. 

Thumbnail

Beacon Nation: 17 Communities Evolve

A look at impressive results these communities achieved through notification systems, care coordination and analytics. 

NovoPath Debuts Web Portal for Patient Access to Test Result Reports

Princeton, NJ, April 14, 2014 – NovoPath introduces a customizable web portal to its NovoPath anatomic pathology laboratory information system (APLIS), helping customers efficiently comply with new legislation requiring labs to provide direct patient access to reports.  The new feature enables patients with test results to log on to a web portal through a lab’s website and download the documents generated through NovoPath’s APLIS.

Cost is key barrier to eRx adoption

Electronic prescribing plays an important role in improving the safety and quality of the prescribing process, however barriers to implementation remain.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.